A Rare Case of Reversible Splenial Lesion Syndrome with Extracallosal Lesions in the Setting of Deep Anemia

Dear Editor,

A 35-year-old female patient was admitted to our emergency department with impairment of consciousness, and somnolence. It was learned that the patient had been suffering from headache and anorexia over the last week. The clinic had begun abruptly, and the patient deteriorated over the last 5 hours before admission. The other medical history was unremarkable, and the patient had no history of recent drug use or an infection. The vital signs at admission to the emergency service were within normal limits. The neurological examination revealed that the patient was nonoriented and mildly cooperative. She could not cooperate properly with the examination and an increase in motor and psychological activity was apparent that was compatible with agitation. Other investigations including motor, sensory, and cerebellar tests were roughly within normal limits. The Kernig's and Brudzinski's signs were negative. The laboratory investigations revealed severe iron deficiency anemia (hemoglobin [Hb]: 5.3 mg/dL, serum ferritin: 30 μg/L), mild hyponatremia (131 mM/L [136–146 mM/L]), hyperkalemia (5.1 mM/L), neutrophilic leukocytosis (neutrophil: 89%), and increment of C-reactive protein (27.9 [0–0.8]). The results of the other investigations including liver-kidney functions, thyroid functions, vitamin B12, and folic acid were within normal limits. The initial cranial magnetic resonance imaging (MRI), performed on the 9th hour of the clinic, was normal ([Fig. 1]). Lumbar puncture investigations revealed normal cerebrospinal fluid (CSF) biochemistry, microscopic examination, and the result of the CSF culture was negative. The infectious disease specialist did not consider an infectious etiology of the central nervous system to explain the clinic. Routine electroencephalogram showed mild slow background activity (7 Hz) without discharge and focal slow activity. At this point, the MRI was repeated the day after, which showed restricted diffusion in the splenium, bilateral corona radiata, and left hippocampus ([Fig. 1]). Two-unit red blood cell (RBC) transfusion was administered for deep anemia (the follow-up test revealed Hb level of 8.3 mg/dL and Na level of 134 mM/L) and methylprednisolone 1 g intravenous treatment was initiated considering a possible underlying limbic encephalitis or autoimmune encephalitis. However, after the RBC transfusion, a marked and rapid clinical improvement was achieved, and the patient completely recovered after 2 days, and methylprednisolone was stopped at the second day of therapy. She was fully oriented and cooperative, and the Glasgow Coma Scale was evaluated as 15 points. The results of the screening tests for tumors including computed tomography (CT) thorax, CT abdomen, and pelvic ultrasound were unremarkable. Besides, the tumor markers were within normal limits. The anti-NMDAR antibody, anti-AMPA1 antibody, anti-AMPA2 antibody, CASPR2 antibody, GABARB1/B2 antibody, and LGI1 antibody tests results were negative. The follow-up MRI, performed 1 week later, showed total resolution of the diffusion-restricted lesions ([Fig. 2]). The retrospective analyses of the results, in light of the related literature data, revealed the diagnosis of reversible splenial lesion syndrome (RESLES).

Fig. 1 (A) The cranial magnetic resonance imaging (MRI), performed at admission (9 hours after initiation of the clinic), shows a normal appearance. (B,C) The second cranial MRI (performed 1 day after the initiation of clinic) showing diffusion restriction in the corpus callosum, bilateral corona radiate, and left hippocampus (B represents the diffusion-weighted imaging [DWI] sequences; C represents the apparent diffusion coefficient [ADC] sequences).

Fig. 2 The cranial magnetic resonance imaging (MRI) shows complete resolution of the diffusion-restricted lesions (A represents diffusion-weighted imaging [DWI] sequences, B represents apparent diffusion coefficient [ADC] sequences, C represents fluid-attenuated inversion recovery [FLAIR] sequences).

Authors' Contributions

HO contributed to the conception, organization, and execution of the paper, and the writing and review of the manuscript. SSC contributed to the conception and review of the paper.

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

Informed Consent

A written informed consent was obtained from study participants. We confirm that we have read the journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

Publikationsverlauf

Artikel online veröffentlicht:
22. September 2023

• References

• 1 Maeda M, Tsukahara H, Terada H. et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 2006; 33 (04) 229-236
• 2 Takanashi J, Maeda M, Hayashi M. Neonate showing reversible splenial lesion. Arch Neurol 2005; 62 (09) 1481-1482 , author reply 1482
• 3 Garcia-Monco JC, Cortina IE, Ferreira E. et al. Reversible splenial lesion syndrome (RESLES): what's in a name?. J Neuroimaging 2011; 21 (02) e1-e14
• 4 Zhang S, Ma Y, Feng J. Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity. Medicine (Baltimore) 2015; 94 (06) e512
• 5 Lu PL, Hodes JF, Zheng X, Hu XY. Reversible splenial lesion syndrome with some novel causes and clinical manifestations. Intern Med 2020; 59 (20) 2471-2480
• 6 Gao X, Feng Q, Arif S, Liaqat J, Li B, Jiang K. Clinical analysis of reversible splenial lesion syndrome in Chinese adults: a retrospective study of 11 cases. Medicine (Baltimore) 2020; 99 (36) e22052
• 7 Kang EG, Jeon SJ, Choi SS, Song CJ, Yu IK. Diffusion MR imaging of hypoglycemic encephalopathy. AJNR Am J Neuroradiol 2010; 31 (03) 559-564
• 8 Reyes-Haro D, Mora-Loyola E, Soria-Ortiz B, García-Colunga J. Regional density of glial cells in the rat corpus callosum. Biol Res 2013; 46 (01) 27-32
• 9 Graves AR, Moore SJ, Bloss EB, Mensh BD, Kath WL, Spruston N. Hippocampal pyramidal neurons comprise two distinct cell types that are countermodulated by metabotropic receptors. Neuron 2012; 76 (04) 776-789
• 10 Mittal RD, Pandey A, Mittal B, Agarwal KN. Effect of latent iron deficiency on gaba and glutamate neuroreceptors in rat brain. Indian J Clin Biochem 2002; 17 (02) 1-6